Latest news
Loading news…
Argo Biopharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Jiading, Shanghai, China Founded 2021 51-100 employees For Profit
Argo Biopharma is an RNAi drug research and development platform focused on siRNA drug development.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 14
Company Info
- Founded
- 2021
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 17
- HQ
- Jiading, Shanghai, China
- Region
- Asia-Pacific (APAC)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.2
- Trend (30d)
- -1.2
- Trend (90d)
- -2.5
- Last leadership hire
- Mar 1, 2026
Key People at Argo Biopharma
Chief Financial Officer and Chief Strategy Officer
Co-Founder, Chief Executive Officer
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Argo Biopharma
Loading news…
FAQs about Argo Biopharma
People who checked this page also checked these
Browse the full Acquirezy directory.